Zydus Lifesciences has launched Anyra, a biosimilar of Regeneron Pharmaceuticals’ Aflibercept 2 mg that is indicated for certain eye diseases.

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

Health experts warn no single type of product can treat all kinds of eye diseases, refuting false social media advertisements circulating in Malaysia touting a brand of eye drops. They advise patients ...

From bionic eyes to cell and gene therapies in clinical therapies, it's an exciting time for emerging technologies aiming to treat blindness and the visually impaired.

In the recreation room at Eskaton Village in Carmichael, Bonnie Dale, one of the residents, is trying on a virtual reality ...

Eye doctors treating vision-threatening infections in drug users are uniquely positioned to connect patients with life-saving ...

Cornerstone Eye Associates has become the first practice in Rochester to offer Valeda Light Therapy for the treatment of dry ...

Discover how tiny, cutting‑edge surgical tools are transforming glaucoma care with a gentler, less invasive approach. Learn why Moran Eye Center experts use MIGS to help protect vision earlier and ...

F or Sale: red eye tree frog,” reads one ad on faunaclassifieds.com, a long-standing exotic pet trade website in the United ...

Learn about causes of gradual and sudden-onset blurred vision, from eyestrain and refractive errors to cataracts and strokes, ...

Struggling with side vision problems? Know subtle warning signs that may indicate serious eye damage and why early screening can help prevent permanent vision loss.

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found.